The disclosed subject matter presents a catalyst or catalyst composition as well as the methods of making and using the catalyst or catalyst composition. In one aspect, the disclosed subject matter relates to a catalyst comprising CoMn.sub.aSi.sub.bX.sub.cY.sub.dO.sub.x wherein in X comprises an element from Group 11; Y comprises an element from Group 12; a ranges from 0.8 to 1.2; b ranges from 0.1 to 1; c ranges from 0.01 to 0.05; d ranges from 0.01 to 0.05; x is a number determined by the valency requirements of the other elements present; and wherein the catalyst converts synthesis gas to at least one olefin.

The present invention relates to a supported catalyst used for synthesizing polyether amine, a preparation method, and an application. The supported catalyst introduces Mo and CeO.sub.2 into Ni and Cu active components. By means of the cooperation of Ni, Cu and Mo, CeO.sub.2 and Ni form more active sites, such that the supported catalyst can have high reaction activity and selectivity. By using the supported catalyst to synthesize polyether amine, the amination efficiency and selectivity of polyether polyol can be greatly enhanced, thereby preparing the polyether amine with light color and narrow molecular weight distribution. In addition, the cost of the catalyst can be reduced, a process condition is relatively mild, and the disadvantage of low reaction activity of a nickel-based catalyst in synthesizing small molecule polyether amine can be overcome, such that the supported catalyst has a desirable industrial application prospect.

A catalyst composition comprising—a support comprising TiO.sub.2,—a composite oxide containing vanadium and antimony, which has a rutile-type structure different from VSbO.sub.4 and V.sub.0.92Sb.sub.0.92O.sub.4 as determined by X-ray diffraction (XRD) analysis with CuKα radiation, and—optionally, one or more selected from the group consisting of oxides of silicon, oxides of vanadium and oxides of antimony, for selective catalytic reduction of nitrogen oxides; to a process for preparing the catalyst composition, to the catalyst composition obtained/obtainable by the process and to use of the same for selective catalytic reduction of nitrogen oxides.

A catalyst composition comprising—a support comprising TiO.sub.2,—a composite oxide containing vanadium and antimony, which has a rutile-type structure different from VSbO.sub.4 and V.sub.0.92Sb.sub.0.92O.sub.4 as determined by X-ray diffraction (XRD) analysis with CuKα radiation, and—optionally, one or more selected from the group consisting of oxides of silicon, oxides of vanadium and oxides of antimony, for selective catalytic reduction of nitrogen oxides; to a process for preparing the catalyst composition, to the catalyst composition obtained/obtainable by the process and to use of the same for selective catalytic reduction of nitrogen oxides.

Methods for making a supported chromium catalyst are disclosed, and can comprise contacting a silica-coated alumina containing at least 30 wt. % silica with a chromium-containing compound in a liquid, drying, and calcining in an oxidizing atmosphere at a peak temperature of at least 650° C. to form the supported chromium catalyst. The supported chromium catalyst can contain from 0.01 to 20 wt. % chromium, and typically can have a pore volume from 0.5 to 2 mL/g and a BET surface area from 275 to 550 m.sup.2/g. The supported chromium catalyst subsequently can be used to polymerize olefins to produce, for example, ethylene-based homopolymers and copolymers having high molecular weights and broad molecular weight distributions.

Methods for making a supported chromium catalyst are disclosed, and can comprise contacting a silica-coated alumina containing at least 30 wt. % silica with a chromium-containing compound in a liquid, drying, and calcining in an oxidizing atmosphere at a peak temperature of at least 650° C. to form the supported chromium catalyst. The supported chromium catalyst can contain from 0.01 to 20 wt. % chromium, and typically can have a pore volume from 0.5 to 2 mL/g and a BET surface area from 275 to 550 m.sup.2/g. The supported chromium catalyst subsequently can be used to polymerize olefins to produce, for example, ethylene-based homopolymers and copolymers having high molecular weights and broad molecular weight distributions.

A catalyst fibrous structure having a catalyst metal carried on a fibrous structure, wherein (a) a Log differential micropore volume distribution curve thereof obtained by measurement using a mercury intrusion technique has a peak having a maximum micropore diameter in the range of from 0.1 μm to 100 μm; (b) a Log differential micropore volume at the peak is 0.5 mL/g or more; and (c) an amount of a catalyst metal compound and a binder carried per unit volume is 0.05 g/mL or more. A production method for producing a catalyst fibrous structure having: (1) mixing a catalyst metal compound or a catalyst precursor, and an inorganic binder and a solvent; (2) grinding the mixture to obtain a coating material of the catalyst metal compound or the catalyst precursor having a median particle diameter of 2 μm or less and a viscosity of from 10 mPa.Math.s to 200 mPa.Math.s; (3) impregnating a fibrous structure with the coating material to fill up voids of the fibrous structure with the coating material of the catalyst metal compound or the catalyst precursor; (4) heating and drying the fibrous structure, directly as it is, at a temperature not lower than the boiling point of the solvent; and (5) heating and calcination the dried fibrous structure at a temperature not lower than the dehydration temperature of the inorganic binder to obtain a catalyst fibrous structure.

A catalyst fibrous structure having a catalyst metal carried on a fibrous structure, wherein (a) a Log differential micropore volume distribution curve thereof obtained by measurement using a mercury intrusion technique has a peak having a maximum micropore diameter in the range of from 0.1 μm to 100 μm; (b) a Log differential micropore volume at the peak is 0.5 mL/g or more; and (c) an amount of a catalyst metal compound and a binder carried per unit volume is 0.05 g/mL or more. A production method for producing a catalyst fibrous structure having: (1) mixing a catalyst metal compound or a catalyst precursor, and an inorganic binder and a solvent; (2) grinding the mixture to obtain a coating material of the catalyst metal compound or the catalyst precursor having a median particle diameter of 2 μm or less and a viscosity of from 10 mPa.Math.s to 200 mPa.Math.s; (3) impregnating a fibrous structure with the coating material to fill up voids of the fibrous structure with the coating material of the catalyst metal compound or the catalyst precursor; (4) heating and drying the fibrous structure, directly as it is, at a temperature not lower than the boiling point of the solvent; and (5) heating and calcination the dried fibrous structure at a temperature not lower than the dehydration temperature of the inorganic binder to obtain a catalyst fibrous structure.

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.